 Charles Robertson
Concepts (503)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microbiota | 42 | 2023 | 656 | 3.910 |
Why?
| | Gastrointestinal Microbiome | 28 | 2023 | 548 | 2.810 |
Why?
| | RNA, Ribosomal, 16S | 44 | 2023 | 514 | 1.820 |
Why?
| | Bacteria | 31 | 2023 | 757 | 1.760 |
Why?
| | Cystic Fibrosis | 12 | 2023 | 964 | 1.020 |
Why?
| | Intestinal Mucosa | 10 | 2020 | 531 | 0.910 |
Why?
| | Feces | 16 | 2023 | 396 | 0.900 |
Why?
| | Otitis Media | 5 | 2023 | 146 | 0.850 |
Why?
| | Intestines | 9 | 2017 | 332 | 0.840 |
Why?
| | Metagenome | 10 | 2019 | 121 | 0.820 |
Why?
| | Rhinitis | 6 | 2020 | 129 | 0.740 |
Why?
| | Biodiversity | 11 | 2020 | 378 | 0.720 |
Why?
| | Water Microbiology | 8 | 2018 | 78 | 0.710 |
Why?
| | Sinusitis | 6 | 2020 | 175 | 0.700 |
Why?
| | Paranasal Sinuses | 5 | 2016 | 64 | 0.630 |
Why?
| | Phylogeny | 13 | 2020 | 816 | 0.600 |
Why?
| | Archaea | 2 | 2008 | 70 | 0.580 |
Why?
| | Air Microbiology | 2 | 2015 | 41 | 0.580 |
Why?
| | Ileum | 4 | 2020 | 100 | 0.560 |
Why?
| | Sequence Analysis, DNA | 14 | 2020 | 755 | 0.540 |
Why?
| | Nasopharynx | 4 | 2022 | 64 | 0.510 |
Why?
| | RNA, Bacterial | 8 | 2018 | 175 | 0.490 |
Why?
| | Breast Feeding | 5 | 2023 | 386 | 0.490 |
Why?
| | Railroads | 1 | 2013 | 5 | 0.460 |
Why?
| | Computer Graphics | 1 | 2013 | 48 | 0.460 |
Why?
| | Database Management Systems | 1 | 2013 | 56 | 0.460 |
Why?
| | User-Computer Interface | 1 | 2013 | 163 | 0.440 |
Why?
| | Geologic Sediments | 2 | 2008 | 37 | 0.410 |
Why?
| | Proton Pump Inhibitors | 3 | 2018 | 98 | 0.410 |
Why?
| | Aerosols | 1 | 2013 | 221 | 0.410 |
Why?
| | Trachea | 4 | 2023 | 226 | 0.410 |
Why?
| | Crohn Disease | 4 | 2020 | 197 | 0.380 |
Why?
| | Colon | 3 | 2023 | 238 | 0.380 |
Why?
| | Fucosyltransferases | 2 | 2022 | 30 | 0.370 |
Why?
| | Lung | 7 | 2021 | 3664 | 0.360 |
Why?
| | Arthritis, Experimental | 2 | 2023 | 133 | 0.350 |
Why?
| | DNA, Bacterial | 8 | 2021 | 314 | 0.350 |
Why?
| | Inflammation | 10 | 2022 | 2566 | 0.350 |
Why?
| | Software | 1 | 2013 | 613 | 0.340 |
Why?
| | Genes, rRNA | 5 | 2015 | 39 | 0.330 |
Why?
| | Humans | 74 | 2023 | 118972 | 0.330 |
Why?
| | Polycystic Ovary Syndrome | 2 | 2021 | 157 | 0.320 |
Why?
| | Case-Control Studies | 15 | 2020 | 3171 | 0.320 |
Why?
| | Non-alcoholic Fatty Liver Disease | 2 | 2022 | 280 | 0.310 |
Why?
| | Sulfolobus solfataricus | 1 | 2007 | 8 | 0.300 |
Why?
| | Male | 49 | 2022 | 57801 | 0.300 |
Why?
| | Bronchoalveolar Lavage Fluid | 4 | 2021 | 613 | 0.290 |
Why?
| | Water Pollutants, Chemical | 2 | 2020 | 174 | 0.290 |
Why?
| | Female | 49 | 2023 | 61564 | 0.290 |
Why?
| | Legionella | 2 | 2017 | 7 | 0.290 |
Why?
| | Dietary Supplements | 3 | 2019 | 467 | 0.280 |
Why?
| | Cryoelectron Microscopy | 1 | 2007 | 139 | 0.280 |
Why?
| | Pseudomonas Infections | 3 | 2023 | 193 | 0.280 |
Why?
| | Fatty Acids, Volatile | 4 | 2019 | 47 | 0.270 |
Why?
| | Drinking Water | 3 | 2017 | 68 | 0.270 |
Why?
| | Fatty Liver | 2 | 2021 | 253 | 0.270 |
Why?
| | Nod2 Signaling Adaptor Protein | 4 | 2019 | 30 | 0.270 |
Why?
| | Environmental Microbiology | 1 | 2005 | 41 | 0.270 |
Why?
| | Molecular Sequence Data | 8 | 2015 | 2871 | 0.260 |
Why?
| | Eosinophilic Esophagitis | 2 | 2022 | 308 | 0.260 |
Why?
| | Colitis, Ulcerative | 2 | 2020 | 105 | 0.260 |
Why?
| | Bacteremia | 2 | 2018 | 161 | 0.260 |
Why?
| | Drug Resistance | 2 | 2017 | 167 | 0.260 |
Why?
| | Metagenomics | 3 | 2019 | 134 | 0.250 |
Why?
| | Construction Materials | 2 | 2015 | 14 | 0.250 |
Why?
| | High-Throughput Nucleotide Sequencing | 7 | 2017 | 453 | 0.250 |
Why?
| | Staphylococcus aureus | 4 | 2021 | 394 | 0.250 |
Why?
| | Liver | 3 | 2020 | 1816 | 0.250 |
Why?
| | Diabetes Mellitus, Type 1 | 6 | 2017 | 3360 | 0.240 |
Why?
| | Animals | 28 | 2023 | 33381 | 0.240 |
Why?
| | Ecosystem | 2 | 2007 | 555 | 0.240 |
Why?
| | Mice | 19 | 2023 | 15520 | 0.240 |
Why?
| | Sputum | 5 | 2020 | 290 | 0.240 |
Why?
| | Infant Formula | 2 | 2023 | 84 | 0.240 |
Why?
| | Adult | 28 | 2022 | 31512 | 0.240 |
Why?
| | Diet, Western | 2 | 2022 | 69 | 0.230 |
Why?
| | Respiratory System | 2 | 2016 | 141 | 0.230 |
Why?
| | Adrenal Cortex Hormones | 3 | 2017 | 521 | 0.230 |
Why?
| | Child | 21 | 2023 | 19129 | 0.230 |
Why?
| | Premature Birth | 3 | 2017 | 284 | 0.230 |
Why?
| | Imaging, Three-Dimensional | 1 | 2007 | 499 | 0.230 |
Why?
| | Mice, Inbred C57BL | 12 | 2022 | 4908 | 0.230 |
Why?
| | Milk, Human | 3 | 2023 | 145 | 0.230 |
Why?
| | Iron | 2 | 2016 | 248 | 0.220 |
Why?
| | Anti-Bacterial Agents | 8 | 2023 | 1510 | 0.220 |
Why?
| | Arthritis, Rheumatoid | 2 | 2023 | 989 | 0.220 |
Why?
| | Inflammatory Bowel Diseases | 3 | 2018 | 290 | 0.220 |
Why?
| | Bile Acids and Salts | 2 | 2022 | 179 | 0.220 |
Why?
| | Staphylococcus | 4 | 2017 | 68 | 0.220 |
Why?
| | Otitis Media, Suppurative | 1 | 2022 | 4 | 0.220 |
Why?
| | Gastrointestinal Tract | 3 | 2015 | 175 | 0.210 |
Why?
| | HIV Infections | 3 | 2022 | 2459 | 0.210 |
Why?
| | Cholesteatoma | 1 | 2022 | 13 | 0.210 |
Why?
| | Haemophilus Infections | 1 | 2022 | 31 | 0.210 |
Why?
| | Transcriptome | 3 | 2021 | 756 | 0.210 |
Why?
| | Anti-Asthmatic Agents | 2 | 2017 | 343 | 0.200 |
Why?
| | Staphylococcal Infections | 3 | 2015 | 346 | 0.200 |
Why?
| | Cross-Sectional Studies | 11 | 2021 | 4552 | 0.200 |
Why?
| | Toxins, Biological | 1 | 2020 | 16 | 0.190 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2012 | 211 | 0.190 |
Why?
| | Colitis | 2 | 2020 | 219 | 0.190 |
Why?
| | Ear, Middle | 4 | 2023 | 92 | 0.190 |
Why?
| | Respiratory Tract Infections | 2 | 2023 | 331 | 0.190 |
Why?
| | Serine Peptidase Inhibitor Kazal-Type 5 | 1 | 2020 | 3 | 0.190 |
Why?
| | Pneumonia, Ventilator-Associated | 1 | 2021 | 41 | 0.190 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2020 | 48 | 0.190 |
Why?
| | Groundwater | 1 | 2020 | 32 | 0.190 |
Why?
| | Perilipin-2 | 2 | 2017 | 36 | 0.190 |
Why?
| | Mucin 5AC | 1 | 2020 | 46 | 0.190 |
Why?
| | Nasal Polyps | 1 | 2020 | 49 | 0.190 |
Why?
| | Adolescent | 18 | 2021 | 18480 | 0.190 |
Why?
| | Sevelamer | 1 | 2020 | 9 | 0.190 |
Why?
| | Hot Springs | 2 | 2012 | 7 | 0.180 |
Why?
| | Birth Weight | 2 | 2020 | 465 | 0.180 |
Why?
| | Pore Forming Cytotoxic Proteins | 1 | 2020 | 16 | 0.180 |
Why?
| | Tobacco Smoke Pollution | 1 | 2023 | 233 | 0.180 |
Why?
| | Biofilms | 3 | 2017 | 231 | 0.180 |
Why?
| | RNA, Ribosomal | 4 | 2013 | 158 | 0.180 |
Why?
| | Bronchopulmonary Dysplasia | 2 | 2017 | 325 | 0.180 |
Why?
| | Respiratory System Agents | 1 | 2020 | 22 | 0.180 |
Why?
| | Burns | 1 | 2023 | 247 | 0.180 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2020 | 125 | 0.180 |
Why?
| | Middle Aged | 20 | 2021 | 27617 | 0.180 |
Why?
| | Bacteroides | 1 | 2019 | 18 | 0.180 |
Why?
| | Corrinoids | 1 | 2019 | 7 | 0.170 |
Why?
| | Inflammation Mediators | 2 | 2020 | 502 | 0.170 |
Why?
| | Body Mass Index | 4 | 2020 | 2092 | 0.170 |
Why?
| | Polymerase Chain Reaction | 7 | 2017 | 1012 | 0.170 |
Why?
| | Dysbiosis | 4 | 2023 | 147 | 0.170 |
Why?
| | Esomeprazole | 1 | 2018 | 6 | 0.170 |
Why?
| | Vitamin B Complex | 1 | 2019 | 37 | 0.170 |
Why?
| | Chronic Disease | 7 | 2022 | 1636 | 0.170 |
Why?
| | Oxonic Acid | 1 | 2018 | 13 | 0.170 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2020 | 157 | 0.170 |
Why?
| | Infant | 10 | 2023 | 8293 | 0.170 |
Why?
| | Diet, High-Fat | 2 | 2017 | 247 | 0.170 |
Why?
| | Intubation, Intratracheal | 2 | 2017 | 226 | 0.170 |
Why?
| | Aminophenols | 1 | 2020 | 112 | 0.160 |
Why?
| | Alphaproteobacteria | 2 | 2016 | 8 | 0.160 |
Why?
| | Intraepithelial Lymphocytes | 1 | 2018 | 12 | 0.160 |
Why?
| | Quinolones | 1 | 2020 | 98 | 0.160 |
Why?
| | Vitamin B 12 | 1 | 2019 | 115 | 0.160 |
Why?
| | Corrosion | 2 | 2015 | 15 | 0.160 |
Why?
| | Chloramines | 2 | 2015 | 11 | 0.160 |
Why?
| | Hydraulic Fracking | 1 | 2018 | 15 | 0.160 |
Why?
| | Down Syndrome | 1 | 2023 | 356 | 0.160 |
Why?
| | Probiotics | 1 | 2018 | 49 | 0.160 |
Why?
| | Spondylarthritis | 1 | 2018 | 35 | 0.160 |
Why?
| | Asthma | 3 | 2017 | 2158 | 0.160 |
Why?
| | Immunity, Innate | 3 | 2019 | 745 | 0.160 |
Why?
| | Dacryocystorhinostomy | 1 | 2017 | 10 | 0.150 |
Why?
| | Infant Nutritional Physiological Phenomena | 2 | 2023 | 131 | 0.150 |
Why?
| | Clostridium Infections | 1 | 2018 | 57 | 0.150 |
Why?
| | Sequence Analysis, RNA | 3 | 2020 | 409 | 0.150 |
Why?
| | Parvovirus | 2 | 2017 | 13 | 0.150 |
Why?
| | Sepsis | 1 | 2023 | 531 | 0.150 |
Why?
| | Young Adult | 11 | 2021 | 10793 | 0.150 |
Why?
| | Respiration, Artificial | 3 | 2023 | 545 | 0.150 |
Why?
| | Hyperuricemia | 1 | 2018 | 134 | 0.150 |
Why?
| | Biomarkers | 5 | 2020 | 3588 | 0.140 |
Why?
| | Diabetes, Gestational | 1 | 2020 | 283 | 0.140 |
Why?
| | Pharynx | 1 | 2016 | 53 | 0.140 |
Why?
| | Lipid Metabolism | 2 | 2020 | 477 | 0.140 |
Why?
| | Vitamin E | 1 | 2016 | 116 | 0.140 |
Why?
| | Rivers | 1 | 2016 | 56 | 0.140 |
Why?
| | Fatigue Syndrome, Chronic | 1 | 2015 | 16 | 0.140 |
Why?
| | Therapeutic Irrigation | 1 | 2016 | 67 | 0.140 |
Why?
| | Ethmoid Sinus | 1 | 2015 | 8 | 0.140 |
Why?
| | Metabolic Syndrome | 1 | 2020 | 394 | 0.140 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2016 | 56 | 0.140 |
Why?
| | Textiles | 1 | 2015 | 19 | 0.130 |
Why?
| | Delivery, Obstetric | 1 | 2016 | 125 | 0.130 |
Why?
| | Adenomatous Polyposis Coli Protein | 1 | 2015 | 18 | 0.130 |
Why?
| | Prospective Studies | 7 | 2022 | 6471 | 0.130 |
Why?
| | Sanitary Engineering | 1 | 2015 | 6 | 0.130 |
Why?
| | Nose | 1 | 2015 | 58 | 0.130 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2015 | 31 | 0.130 |
Why?
| | Bronchi | 1 | 2016 | 242 | 0.130 |
Why?
| | Health Facilities | 1 | 2015 | 75 | 0.130 |
Why?
| | Vaccines, Conjugate | 1 | 2015 | 63 | 0.130 |
Why?
| | Dietary Fats | 1 | 2017 | 322 | 0.130 |
Why?
| | Bacteriology | 1 | 2014 | 3 | 0.130 |
Why?
| | Base Sequence | 3 | 2015 | 2159 | 0.130 |
Why?
| | Infant, Newborn | 7 | 2023 | 5255 | 0.130 |
Why?
| | Child, Preschool | 8 | 2023 | 9491 | 0.130 |
Why?
| | Biota | 1 | 2015 | 37 | 0.130 |
Why?
| | Humidity | 1 | 2014 | 45 | 0.130 |
Why?
| | Household Articles | 1 | 2014 | 22 | 0.130 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2020 | 468 | 0.130 |
Why?
| | Oropharynx | 1 | 2015 | 41 | 0.130 |
Why?
| | Leptin | 1 | 2016 | 231 | 0.130 |
Why?
| | Antibiotic Prophylaxis | 1 | 2015 | 100 | 0.130 |
Why?
| | Siblings | 1 | 2015 | 235 | 0.120 |
Why?
| | Aged | 11 | 2023 | 19657 | 0.120 |
Why?
| | Rats | 6 | 2023 | 5392 | 0.120 |
Why?
| | Disease Models, Animal | 6 | 2020 | 3730 | 0.120 |
Why?
| | Colorectal Neoplasms | 1 | 2021 | 628 | 0.120 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2020 | 589 | 0.120 |
Why?
| | Hippocampus | 1 | 2018 | 735 | 0.120 |
Why?
| | Child Development Disorders, Pervasive | 1 | 2014 | 61 | 0.120 |
Why?
| | Hydrogen Sulfide | 1 | 2014 | 40 | 0.120 |
Why?
| | Toll-Like Receptor 3 | 1 | 2013 | 31 | 0.120 |
Why?
| | Pneumococcal Vaccines | 1 | 2015 | 140 | 0.120 |
Why?
| | Cecum | 3 | 2020 | 37 | 0.120 |
Why?
| | Computational Biology | 2 | 2019 | 588 | 0.120 |
Why?
| | Age Factors | 2 | 2019 | 2995 | 0.120 |
Why?
| | Gram-Positive Bacteria | 1 | 2013 | 47 | 0.120 |
Why?
| | Parenteral Nutrition | 1 | 2014 | 92 | 0.120 |
Why?
| | Nasal Cavity | 1 | 2013 | 47 | 0.120 |
Why?
| | Saliva | 1 | 2015 | 188 | 0.120 |
Why?
| | DNA, Ribosomal | 2 | 2015 | 79 | 0.120 |
Why?
| | Cities | 1 | 2013 | 96 | 0.120 |
Why?
| | Soil Microbiology | 1 | 2015 | 183 | 0.120 |
Why?
| | Bacteroidetes | 3 | 2021 | 22 | 0.120 |
Why?
| | Autoantibodies | 2 | 2018 | 1335 | 0.110 |
Why?
| | Genetic Variation | 1 | 2018 | 926 | 0.110 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2013 | 95 | 0.110 |
Why?
| | Pediatric Obesity | 1 | 2020 | 524 | 0.110 |
Why?
| | New York City | 1 | 2013 | 75 | 0.110 |
Why?
| | HIV-1 | 1 | 2019 | 776 | 0.110 |
Why?
| | Gastric Bypass | 1 | 2014 | 93 | 0.110 |
Why?
| | Iron, Dietary | 1 | 2013 | 19 | 0.110 |
Why?
| | Membrane Proteins | 2 | 2019 | 1055 | 0.110 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2015 | 190 | 0.110 |
Why?
| | Prednisone | 1 | 2013 | 235 | 0.110 |
Why?
| | Infant Food | 1 | 2013 | 63 | 0.110 |
Why?
| | Real-Time Polymerase Chain Reaction | 3 | 2021 | 333 | 0.110 |
Why?
| | Seawater | 1 | 2012 | 24 | 0.110 |
Why?
| | Mexico | 2 | 2012 | 165 | 0.110 |
Why?
| | Antioxidants | 1 | 2016 | 564 | 0.110 |
Why?
| | Bacterial Infections | 1 | 2014 | 227 | 0.110 |
Why?
| | Gastroesophageal Reflux | 1 | 2015 | 248 | 0.110 |
Why?
| | Carbon Dioxide | 1 | 2014 | 230 | 0.110 |
Why?
| | Paneth Cells | 1 | 2012 | 18 | 0.110 |
Why?
| | Xenobiotics | 1 | 2012 | 25 | 0.110 |
Why?
| | Anti-Infective Agents | 1 | 2015 | 227 | 0.110 |
Why?
| | Bacterial Translocation | 1 | 2012 | 36 | 0.110 |
Why?
| | Body Fluids | 1 | 2012 | 62 | 0.110 |
Why?
| | Islets of Langerhans | 2 | 2015 | 739 | 0.100 |
Why?
| | Gonadal Steroid Hormones | 1 | 2013 | 122 | 0.100 |
Why?
| | Sequence Analysis | 1 | 2011 | 36 | 0.100 |
Why?
| | Obesity, Morbid | 1 | 2014 | 197 | 0.100 |
Why?
| | Mice, Knockout | 4 | 2022 | 2680 | 0.100 |
Why?
| | Kidney | 1 | 2018 | 1353 | 0.100 |
Why?
| | Cytokines | 2 | 2018 | 1900 | 0.100 |
Why?
| | Autism Spectrum Disorder | 1 | 2015 | 323 | 0.100 |
Why?
| | Stress, Psychological | 1 | 2018 | 972 | 0.100 |
Why?
| | Indoles | 1 | 2013 | 316 | 0.100 |
Why?
| | Autoimmunity | 2 | 2015 | 831 | 0.090 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2014 | 366 | 0.090 |
Why?
| | Esophagus | 1 | 2012 | 237 | 0.090 |
Why?
| | Phenotype | 5 | 2020 | 3003 | 0.090 |
Why?
| | Obesity | 2 | 2021 | 2746 | 0.090 |
Why?
| | Genes, Bacterial | 3 | 2018 | 162 | 0.090 |
Why?
| | Dextran Sulfate | 2 | 2020 | 71 | 0.090 |
Why?
| | Weight Loss | 1 | 2014 | 655 | 0.090 |
Why?
| | Cohort Studies | 5 | 2019 | 5116 | 0.090 |
Why?
| | Cholesterol | 2 | 2022 | 373 | 0.090 |
Why?
| | Pseudomonas aeruginosa | 2 | 2023 | 305 | 0.090 |
Why?
| | Pacific Ocean | 1 | 2008 | 5 | 0.090 |
Why?
| | RNA, Archaeal | 1 | 2008 | 13 | 0.090 |
Why?
| | Genotype | 4 | 2019 | 1882 | 0.090 |
Why?
| | DNA, Archaeal | 1 | 2008 | 16 | 0.090 |
Why?
| | Pregnancy | 5 | 2020 | 5690 | 0.090 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2008 | 155 | 0.080 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2174 | 0.080 |
Why?
| | Firmicutes | 2 | 2021 | 20 | 0.080 |
Why?
| | Exome | 2 | 2020 | 220 | 0.080 |
Why?
| | Pedigree | 2 | 2020 | 485 | 0.080 |
Why?
| | Lactobacillus | 2 | 2020 | 23 | 0.080 |
Why?
| | Sex Characteristics | 1 | 2013 | 671 | 0.080 |
Why?
| | Smoke | 2 | 2023 | 143 | 0.080 |
Why?
| | Methane | 2 | 2020 | 43 | 0.080 |
Why?
| | Bacterial Load | 2 | 2021 | 61 | 0.080 |
Why?
| | Fatty Acids | 2 | 2022 | 407 | 0.080 |
Why?
| | Cryoprotective Agents | 1 | 2007 | 12 | 0.070 |
Why?
| | Models, Statistical | 1 | 2011 | 636 | 0.070 |
Why?
| | Bacterial Physiological Phenomena | 1 | 2007 | 57 | 0.070 |
Why?
| | Freezing | 1 | 2007 | 87 | 0.070 |
Why?
| | Gammaproteobacteria | 2 | 2016 | 14 | 0.070 |
Why?
| | Equipment Contamination | 2 | 2017 | 55 | 0.070 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2020 | 982 | 0.070 |
Why?
| | Carrier Proteins | 1 | 2010 | 726 | 0.070 |
Why?
| | Genes, Archaeal | 1 | 2005 | 7 | 0.070 |
Why?
| | Insulin | 1 | 2016 | 2162 | 0.070 |
Why?
| | Disease Susceptibility | 2 | 2020 | 331 | 0.070 |
Why?
| | Cryopreservation | 1 | 2007 | 99 | 0.070 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2014 | 1137 | 0.070 |
Why?
| | Principal Component Analysis | 2 | 2017 | 180 | 0.070 |
Why?
| | Diabetes Mellitus | 1 | 2013 | 942 | 0.070 |
Why?
| | Rats, Inbred Lew | 2 | 2017 | 87 | 0.070 |
Why?
| | Treatment Outcome | 5 | 2020 | 9342 | 0.060 |
Why?
| | Water Purification | 2 | 2017 | 131 | 0.060 |
Why?
| | Body Composition | 2 | 2021 | 653 | 0.060 |
Why?
| | Gestational Age | 2 | 2017 | 765 | 0.060 |
Why?
| | Disinfection | 2 | 2017 | 108 | 0.060 |
Why?
| | Gene Expression Regulation | 1 | 2013 | 2445 | 0.060 |
Why?
| | Aged, 80 and over | 3 | 2021 | 6561 | 0.060 |
Why?
| | RNA, Messenger | 3 | 2018 | 2657 | 0.060 |
Why?
| | Neoplasms | 1 | 2018 | 2179 | 0.060 |
Why?
| | Administration, Oral | 2 | 2019 | 756 | 0.060 |
Why?
| | Tobramycin | 1 | 2023 | 50 | 0.060 |
Why?
| | Geography | 2 | 2014 | 190 | 0.060 |
Why?
| | Colorado | 3 | 2020 | 4196 | 0.060 |
Why?
| | Interleukin-17 | 1 | 2023 | 105 | 0.060 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2015 | 536 | 0.060 |
Why?
| | Animal Husbandry | 1 | 2023 | 33 | 0.060 |
Why?
| | Azithromycin | 1 | 2023 | 81 | 0.060 |
Why?
| | Multivariate Analysis | 2 | 2017 | 1474 | 0.060 |
Why?
| | Sanitation | 1 | 2023 | 52 | 0.060 |
Why?
| | Ammonia | 1 | 2023 | 65 | 0.060 |
Why?
| | Tryptophan | 1 | 2023 | 139 | 0.060 |
Why?
| | Housing, Animal | 1 | 2023 | 46 | 0.060 |
Why?
| | Neutrophils | 2 | 2021 | 1233 | 0.050 |
Why?
| | Linear Models | 2 | 2016 | 827 | 0.050 |
Why?
| | Cotinine | 1 | 2023 | 76 | 0.050 |
Why?
| | Flow Cytometry | 2 | 2017 | 1085 | 0.050 |
Why?
| | Brain | 1 | 2014 | 2490 | 0.050 |
Why?
| | Water | 2 | 2018 | 425 | 0.050 |
Why?
| | Chemokines | 1 | 2023 | 230 | 0.050 |
Why?
| | Virulence | 1 | 2023 | 240 | 0.050 |
Why?
| | Haemophilus influenzae | 1 | 2022 | 50 | 0.050 |
Why?
| | Longitudinal Studies | 2 | 2020 | 2513 | 0.050 |
Why?
| | Administration, Inhalation | 1 | 2023 | 656 | 0.050 |
Why?
| | Endoscopy | 2 | 2015 | 272 | 0.050 |
Why?
| | Multigene Family | 2 | 2012 | 200 | 0.050 |
Why?
| | Ligands | 1 | 2023 | 567 | 0.050 |
Why?
| | Collagen | 1 | 2023 | 433 | 0.050 |
Why?
| | Predictive Value of Tests | 2 | 2018 | 1868 | 0.050 |
Why?
| | Aerobiosis | 1 | 2020 | 21 | 0.050 |
Why?
| | Bacterial Proteins | 2 | 2018 | 759 | 0.050 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2022 | 200 | 0.050 |
Why?
| | Mice, Inbred NOD | 2 | 2013 | 574 | 0.050 |
Why?
| | Ear, External | 1 | 2020 | 24 | 0.050 |
Why?
| | Oil and Gas Fields | 1 | 2020 | 32 | 0.050 |
Why?
| | Hospitals | 2 | 2015 | 598 | 0.050 |
Why?
| | Drug Administration Schedule | 2 | 2013 | 736 | 0.050 |
Why?
| | Smoking | 2 | 2020 | 1487 | 0.050 |
Why?
| | Protective Factors | 1 | 2020 | 92 | 0.050 |
Why?
| | Mouth | 1 | 2020 | 74 | 0.050 |
Why?
| | Fibrosis | 1 | 2022 | 483 | 0.050 |
Why?
| | Sweat | 1 | 2020 | 38 | 0.050 |
Why?
| | Cell Line | 2 | 2018 | 2707 | 0.050 |
Why?
| | Chemokine CCL2 | 1 | 2020 | 126 | 0.040 |
Why?
| | Diet | 2 | 2019 | 1153 | 0.040 |
Why?
| | Glucose Tolerance Test | 1 | 2021 | 368 | 0.040 |
Why?
| | Collagen Type I | 1 | 2020 | 114 | 0.040 |
Why?
| | X-Box Binding Protein 1 | 1 | 2019 | 8 | 0.040 |
Why?
| | Restraint, Physical | 1 | 2018 | 94 | 0.040 |
Why?
| | Cytoprotection | 1 | 2018 | 55 | 0.040 |
Why?
| | Risk Factors | 3 | 2017 | 9000 | 0.040 |
Why?
| | Environmental Monitoring | 1 | 2020 | 296 | 0.040 |
Why?
| | COS Cells | 1 | 2018 | 184 | 0.040 |
Why?
| | Collagen Type II | 1 | 2018 | 48 | 0.040 |
Why?
| | Forced Expiratory Volume | 1 | 2020 | 520 | 0.040 |
Why?
| | Digestive System Surgical Procedures | 1 | 2019 | 91 | 0.040 |
Why?
| | HIV Seropositivity | 1 | 2019 | 111 | 0.040 |
Why?
| | Prognosis | 2 | 2020 | 3443 | 0.040 |
Why?
| | Random Allocation | 1 | 2018 | 344 | 0.040 |
Why?
| | Fetal Membranes, Premature Rupture | 1 | 2017 | 38 | 0.040 |
Why?
| | Immunity, Mucosal | 1 | 2018 | 86 | 0.040 |
Why?
| | Chorioamnionitis | 1 | 2017 | 37 | 0.040 |
Why?
| | New Orleans | 1 | 2017 | 13 | 0.040 |
Why?
| | Pancrelipase | 1 | 2017 | 6 | 0.040 |
Why?
| | Critical Illness | 1 | 2023 | 662 | 0.040 |
Why?
| | Rats, Wistar | 1 | 2018 | 399 | 0.040 |
Why?
| | Infant, Very Low Birth Weight | 1 | 2017 | 68 | 0.040 |
Why?
| | Bacterial Toxins | 1 | 2018 | 106 | 0.040 |
Why?
| | Transforming Growth Factor beta | 1 | 2020 | 462 | 0.040 |
Why?
| | Infant, Extremely Premature | 1 | 2017 | 58 | 0.040 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2017 | 196 | 0.040 |
Why?
| | Mice, Inbred BALB C | 1 | 2020 | 1206 | 0.040 |
Why?
| | Hydroxamic Acids | 1 | 2017 | 80 | 0.040 |
Why?
| | Water Supply | 1 | 2017 | 71 | 0.040 |
Why?
| | Betaproteobacteria | 1 | 2016 | 6 | 0.040 |
Why?
| | Homeostasis | 1 | 2020 | 594 | 0.040 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2020 | 288 | 0.040 |
Why?
| | Intensive Care Units | 1 | 2021 | 635 | 0.040 |
Why?
| | Lactobacillales | 1 | 2016 | 6 | 0.040 |
Why?
| | Magnetic Resonance Imaging | 2 | 2021 | 3174 | 0.040 |
Why?
| | Ferritins | 1 | 2016 | 61 | 0.040 |
Why?
| | Metabolic Networks and Pathways | 1 | 2017 | 176 | 0.040 |
Why?
| | Pyruvate Kinase | 1 | 2016 | 20 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2018 | 625 | 0.040 |
Why?
| | Ohio | 1 | 2016 | 141 | 0.040 |
Why?
| | Bacillus | 1 | 2015 | 14 | 0.030 |
Why?
| | Plethysmography | 1 | 2016 | 124 | 0.030 |
Why?
| | Antibiosis | 1 | 2015 | 7 | 0.030 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2017 | 256 | 0.030 |
Why?
| | Streptococcus mitis | 1 | 2015 | 8 | 0.030 |
Why?
| | Polymorphism, Genetic | 1 | 2019 | 642 | 0.030 |
Why?
| | Catalase | 1 | 2015 | 123 | 0.030 |
Why?
| | Rectum | 1 | 2016 | 157 | 0.030 |
Why?
| | Capsule Endoscopes | 1 | 2015 | 8 | 0.030 |
Why?
| | Pre-Eclampsia | 1 | 2017 | 183 | 0.030 |
Why?
| | Uric Acid | 1 | 2018 | 354 | 0.030 |
Why?
| | Diet, Fat-Restricted | 1 | 2015 | 76 | 0.030 |
Why?
| | Leukocyte L1 Antigen Complex | 1 | 2015 | 32 | 0.030 |
Why?
| | Pseudomonas | 1 | 2015 | 27 | 0.030 |
Why?
| | Kenya | 1 | 2015 | 100 | 0.030 |
Why?
| | Pennsylvania | 1 | 2015 | 101 | 0.030 |
Why?
| | Carrier State | 1 | 2015 | 57 | 0.030 |
Why?
| | Spleen | 1 | 2017 | 510 | 0.030 |
Why?
| | Corynebacterium | 1 | 2015 | 37 | 0.030 |
Why?
| | Enterobacteriaceae | 1 | 2015 | 33 | 0.030 |
Why?
| | Regression Analysis | 1 | 2017 | 983 | 0.030 |
Why?
| | Molecular Typing | 1 | 2014 | 18 | 0.030 |
Why?
| | Verrucomicrobia | 1 | 2014 | 6 | 0.030 |
Why?
| | Vagina | 1 | 2016 | 148 | 0.030 |
Why?
| | Plant Oils | 1 | 2014 | 28 | 0.030 |
Why?
| | Proteobacteria | 1 | 2014 | 17 | 0.030 |
Why?
| | Enterobacteriaceae Infections | 1 | 2015 | 34 | 0.030 |
Why?
| | Permeability | 1 | 2015 | 156 | 0.030 |
Why?
| | Kupffer Cells | 1 | 2014 | 47 | 0.030 |
Why?
| | Bronchoalveolar Lavage | 1 | 2014 | 89 | 0.030 |
Why?
| | Colony Count, Microbial | 1 | 2014 | 120 | 0.030 |
Why?
| | DNA | 2 | 2014 | 1388 | 0.030 |
Why?
| | Physical Exertion | 1 | 2015 | 222 | 0.030 |
Why?
| | Perioperative Care | 1 | 2015 | 132 | 0.030 |
Why?
| | Spirometry | 1 | 2015 | 263 | 0.030 |
Why?
| | Lymph Nodes | 1 | 2017 | 455 | 0.030 |
Why?
| | Porosity | 1 | 2014 | 93 | 0.030 |
Why?
| | Streptococcus pneumoniae | 1 | 2015 | 141 | 0.030 |
Why?
| | Poly I-C | 1 | 2013 | 55 | 0.030 |
Why?
| | Toll-Like Receptor 9 | 1 | 2013 | 30 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 1945 | 0.030 |
Why?
| | Observer Variation | 1 | 2014 | 309 | 0.030 |
Why?
| | Cluster Analysis | 1 | 2015 | 481 | 0.030 |
Why?
| | Pilot Projects | 1 | 2018 | 1419 | 0.030 |
Why?
| | Connectome | 1 | 2014 | 63 | 0.030 |
Why?
| | Nitrates | 1 | 2013 | 78 | 0.030 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2014 | 140 | 0.030 |
Why?
| | Cell Separation | 1 | 2014 | 296 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2012 | 2062 | 0.030 |
Why?
| | Gene Expression | 1 | 2018 | 1489 | 0.030 |
Why?
| | Seasons | 1 | 2015 | 461 | 0.030 |
Why?
| | Mice, Inbred Strains | 1 | 2013 | 405 | 0.030 |
Why?
| | Infant, Premature | 1 | 2017 | 480 | 0.030 |
Why?
| | Trimethoprim | 1 | 2012 | 6 | 0.030 |
Why?
| | Sulfadoxine | 1 | 2012 | 4 | 0.030 |
Why?
| | Sulfamethoxazole | 1 | 2012 | 6 | 0.030 |
Why?
| | Peyer's Patches | 1 | 2012 | 8 | 0.030 |
Why?
| | Liver Cirrhosis | 1 | 2015 | 245 | 0.030 |
Why?
| | Hot Temperature | 1 | 2015 | 334 | 0.030 |
Why?
| | Aging | 1 | 2023 | 1670 | 0.030 |
Why?
| | Expressed Sequence Tags | 1 | 2012 | 38 | 0.030 |
Why?
| | Surgical Wound Infection | 1 | 2015 | 251 | 0.030 |
Why?
| | DNA, Viral | 1 | 2014 | 356 | 0.030 |
Why?
| | Neural Pathways | 1 | 2014 | 277 | 0.030 |
Why?
| | Rats, Inbred Strains | 1 | 2012 | 394 | 0.030 |
Why?
| | Genetic Markers | 1 | 2013 | 348 | 0.030 |
Why?
| | Lubiprostone | 1 | 2012 | 9 | 0.030 |
Why?
| | Ribosome Subunits, Small, Eukaryotic | 1 | 2012 | 8 | 0.030 |
Why?
| | Phototrophic Processes | 1 | 2012 | 2 | 0.030 |
Why?
| | Alprostadil | 1 | 2012 | 32 | 0.030 |
Why?
| | Protein Interaction Maps | 1 | 2012 | 36 | 0.030 |
Why?
| | Electrolytes | 1 | 2012 | 59 | 0.030 |
Why?
| | Chlorine | 1 | 2012 | 55 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2016 | 1687 | 0.030 |
Why?
| | Molecular Sequence Annotation | 1 | 2012 | 91 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2674 | 0.030 |
Why?
| | Skin | 1 | 2016 | 657 | 0.030 |
Why?
| | Genome, Bacterial | 1 | 2012 | 109 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2018 | 1178 | 0.030 |
Why?
| | Chloride Channel Agonists | 1 | 2012 | 58 | 0.030 |
Why?
| | Drug Combinations | 1 | 2012 | 291 | 0.030 |
Why?
| | Suction | 1 | 2011 | 32 | 0.030 |
Why?
| | Blood Glucose | 1 | 2021 | 1939 | 0.030 |
Why?
| | Genetic Predisposition to Disease | 1 | 2020 | 2275 | 0.030 |
Why?
| | Anti-Inflammatory Agents | 1 | 2015 | 465 | 0.030 |
Why?
| | Respiratory Function Tests | 1 | 2013 | 526 | 0.030 |
Why?
| | Cyanobacteria | 1 | 2012 | 62 | 0.020 |
Why?
| | Epithelial Cells | 1 | 2017 | 963 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2020 | 4596 | 0.020 |
Why?
| | Body Weight | 1 | 2015 | 934 | 0.020 |
Why?
| | Databases, Genetic | 1 | 2012 | 253 | 0.020 |
Why?
| | Equipment Design | 1 | 2012 | 519 | 0.020 |
Why?
| | Nutritional Status | 1 | 2013 | 300 | 0.020 |
Why?
| | Escherichia coli Proteins | 1 | 2012 | 170 | 0.020 |
Why?
| | Autophagy-Related Proteins | 1 | 2010 | 46 | 0.020 |
Why?
| | Macrophages, Alveolar | 1 | 2013 | 359 | 0.020 |
Why?
| | Disease Progression | 1 | 2017 | 2490 | 0.020 |
Why?
| | Gene Regulatory Networks | 1 | 2012 | 239 | 0.020 |
Why?
| | Adiposity | 1 | 2015 | 516 | 0.020 |
Why?
| | Laparoscopy | 1 | 2014 | 417 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2012 | 770 | 0.020 |
Why?
| | Models, Genetic | 1 | 2012 | 595 | 0.020 |
Why?
| | Mutation | 1 | 2020 | 3457 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2017 | 4077 | 0.020 |
Why?
| | Risk | 1 | 2011 | 853 | 0.020 |
Why?
| | Biopsy | 1 | 2012 | 1079 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2015 | 1597 | 0.020 |
Why?
| | Escherichia coli | 1 | 2012 | 758 | 0.020 |
Why?
| | Thermus | 1 | 2007 | 1 | 0.020 |
Why?
| | Mining | 1 | 2007 | 16 | 0.020 |
Why?
| | Chloroflexi | 1 | 2007 | 12 | 0.020 |
Why?
| | Macrophages | 1 | 2014 | 1324 | 0.020 |
Why?
| | Vaccination | 1 | 2015 | 1222 | 0.020 |
Why?
| | Peptides | 1 | 2012 | 879 | 0.020 |
Why?
| | Hospitalization | 1 | 2015 | 1785 | 0.020 |
Why?
| | Temperature | 1 | 2007 | 622 | 0.020 |
Why?
| | United States | 1 | 2015 | 12555 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2012 | 12978 | 0.010 |
Why?
|
|
Robertson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|